OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

CDK6—a review of the past and a glimpse into the future: from cell-cycle control to transcriptional regulation
A-S Tigan, Florian Bellutti, Karoline Kollmann, et al.
Oncogene (2015) Vol. 35, Iss. 24, pp. 3083-3091
Open Access | Times Cited: 161

Showing 1-25 of 161 citing articles:

Medulloblastoma
Paul A. Northcott, Giles Robinson, Christian P. Kratz, et al.
Nature Reviews Disease Primers (2019) Vol. 5, Iss. 1
Closed Access | Times Cited: 484

Acquired CDK6 amplification promotes breast cancer resistance to CDK4/6 inhibitors and loss of ER signaling and dependence
Chengcheng Yang, Z Li, Trusha Bhatt, et al.
Oncogene (2016) Vol. 36, Iss. 16, pp. 2255-2264
Open Access | Times Cited: 362

Molecular mechanisms of resistance to CDK4/6 inhibitors in breast cancer: A review
Kamal Pandey, Hee Jung An, Seung-Ki Kim, et al.
International Journal of Cancer (2018) Vol. 145, Iss. 5, pp. 1179-1188
Open Access | Times Cited: 291

Mechanisms of Sensitivity and Resistance to CDK4/6 Inhibition
Mónica Álvarez‐Fernández, Marcos Malumbres
Cancer Cell (2020) Vol. 37, Iss. 4, pp. 514-529
Open Access | Times Cited: 279

Structural insights into the functional diversity of the CDK–cyclin family
D.J. Wood, Jane Endicott
Open Biology (2018) Vol. 8, Iss. 9
Open Access | Times Cited: 223

Homolog-Selective Degradation as a Strategy to Probe the Function of CDK6 in AML
Matthias Brand, Baishan Jiang, Sophie Bauer, et al.
Cell chemical biology (2018) Vol. 26, Iss. 2, pp. 300-306.e9
Open Access | Times Cited: 216

Cell-Cycle Proteins Control Production of Neutrophil Extracellular Traps
Borko Amulic, Sebastian Lorenz Knackstedt, Ulrike Abu Abed, et al.
Developmental Cell (2017) Vol. 43, Iss. 4, pp. 449-462.e5
Open Access | Times Cited: 204

Cyclin dependent kinase (CDK) inhibitors as anticancer drugs: Recent advances (2015–2019)
Concepción Sánchez‐Martínez, Marı́a José Lallena, Sonia Gutiérrez Sanfeliciano, et al.
Bioorganic & Medicinal Chemistry Letters (2019) Vol. 29, Iss. 20, pp. 126637-126637
Closed Access | Times Cited: 178

The role of CDK6 in cancer
Sofie Nebenfuehr, Karoline Kollmann, Veronika Sexl
International Journal of Cancer (2020) Vol. 147, Iss. 11, pp. 2988-2995
Open Access | Times Cited: 139

New and Emerging Targeted Therapies for Advanced Breast Cancer
Kristie Lau, Alexandra M. Tan, Yihui Shi
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 4, pp. 2288-2288
Open Access | Times Cited: 106

Targeted protein degradation: current and future challenges
Alexander Hanzl, Georg E. Winter
Current Opinion in Chemical Biology (2020) Vol. 56, pp. 35-41
Open Access | Times Cited: 124

Systematic exploration of different E3 ubiquitin ligases: an approach towards potent and selective CDK6 degraders
Christian Steinebach, Yuen Lam Dora Ng, Izidor Sosič, et al.
Chemical Science (2020) Vol. 11, Iss. 13, pp. 3474-3486
Open Access | Times Cited: 106

Aging effects on intestinal homeostasis associated with expansion and dysfunction of intestinal epithelial stem cells
Emily C. Moorefield, Sarah F. Andres, R. Eric Blue, et al.
Aging (2017) Vol. 9, Iss. 8, pp. 1898-1915
Open Access | Times Cited: 94

Third-generation CDK inhibitors: A review on the synthesis and binding modes of Palbociclib, Ribociclib and Abemaciclib
Melania Poratti, Giovanni Marzaro
European Journal of Medicinal Chemistry (2019) Vol. 172, pp. 143-153
Closed Access | Times Cited: 94

Proteolysis targeting chimeras (PROTACs) are emerging therapeutics for hematologic malignancies
Yonghan He, Sajid Khan, Zhiguang Huo, et al.
Journal of Hematology & Oncology (2020) Vol. 13, Iss. 1
Open Access | Times Cited: 92

Cyclin-Dependent Kinases 4/6 Inhibitors in Breast Cancer: Current Status, Resistance, and Combination Strategies
Yingjie Niu, Junnan Xu, Tao Sun
Journal of Cancer (2019) Vol. 10, Iss. 22, pp. 5504-5517
Open Access | Times Cited: 78

Redundant and specific roles of cohesin STAG subunits in chromatin looping and transcriptional control
Valentina Casà, Macarena Moronta Gines, Eduardo Gade Gusmao, et al.
Genome Research (2020) Vol. 30, Iss. 4, pp. 515-527
Open Access | Times Cited: 78

CDK4/6 inhibitor resistance mechanisms and treatment strategies (Review)
Jinyao Huang, Liang Zheng, Zicheng Sun, et al.
International Journal of Molecular Medicine (2022) Vol. 50, Iss. 4
Open Access | Times Cited: 64

Lessons Learned from Past Cyclin-Dependent Kinase Drug Discovery Efforts
Zhouling Xie, Shuzeng Hou, Xiaoxiao Yang, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 9, pp. 6356-6389
Closed Access | Times Cited: 46

CDK6-PI3K signaling axis is an efficient target for attenuating ABCB1/P-gp mediated multi-drug resistance (MDR) in cancer cells
Lei Zhang, Yidong Li, Chaohua Hu, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 41

Cell cycle related long non-coding RNAs as the critical regulators of breast cancer progression and metastasis
Amir Sadra Zangouei, Malihe Zangoue, Negin Taghehchian, et al.
Biological Research (2023) Vol. 56, Iss. 1
Open Access | Times Cited: 27

DDX20 is required for cell-cycle reentry of prospermatogonia and establishment of spermatogonial stem cell pool during testicular development in mice
Dingfeng Zou, Kai Li, Luying Su, et al.
Developmental Cell (2024) Vol. 59, Iss. 13, pp. 1707-1723.e8
Closed Access | Times Cited: 8

Insights into phosphorylation-induced influences on conformations and inhibitor binding of CDK6 through GaMD trajectory-based deep learning
Lu Zhao, Jian Wang, Wanchun Yang, et al.
Physical Chemistry Chemical Physics (2025)
Closed Access | Times Cited: 1

Page 1 - Next Page

Scroll to top